Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Bibeau buys 100,000 shares @ .095

<Now these sleuths have determined that the MMP is being sold.>

No, there isn't any such determination. Just logical deduction. Both TPL and PTSC need short term financial support. What do they have that has value that anyone might want some of? Perhaps you see some other source of funding?

Share
New Message
Please login to post a reply